Literature DB >> 31209102

CD27 Promotes CD4+ Effector T Cell Survival in Response to Tissue Self-Antigen.

Kelly A Remedios1,2, Lauren Meyer3, Bahar Zirak1, Mariela L Pauli1, Hong-An Truong2, Devi Boda1, Michael D Rosenblum4.   

Abstract

Signaling through CD27 plays a role in T cell activation and memory. However, it is currently unknown how this costimulatory receptor influences CD4+ effector T (Teff) cells in inflamed tissues. In the current study, we used a murine model of inducible self-antigen expression in the epidermis to elucidate the functional role of CD27 on autoreactive Teff cells. Expression of CD27 on Ag-specific Teff cells resulted in enhanced skin inflammation when compared with CD27-deficient Teff cells. CD27 signaling promoted the accumulation of IFN-γ and IL-2-producing T cells in skin draining lymph nodes in a cell-intrinsic fashion. Surprisingly, this costimulatory pathway had minimal effect on early T cell activation and proliferation. Instead, signaling through CD27 resulted in the progressive survival of Teff cells during the autoimmune response. Using BH3 profiling to assess mitochondrial cell priming, we found that CD27-deficient cells were equally as sensitive as CD27-sufficient cells to mitochondrial outer membrane polarization upon exposure to either BH3 activator or sensitizer peptides. In contrast, CD27-deficient Teff cells expressed higher levels of active caspase 8. Taken together, these results suggest that CD27 does not promote Teff cell survival by increasing expression of antiapoptotic BCL2 family members but instead acts by preferentially suppressing the cell-extrinsic apoptosis pathway, highlighting a previously unidentified role for CD27 in augmenting autoreactive Teff cell responses.
Copyright © 2019 by The American Association of Immunologists, Inc.

Entities:  

Year:  2019        PMID: 31209102      PMCID: PMC6650327          DOI: 10.4049/jimmunol.1900288

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

1.  CD27 is required for generation and long-term maintenance of T cell immunity.

Authors:  J Hendriks; L A Gravestein; K Tesselaar; R A van Lier; T N Schumacher; J Borst
Journal:  Nat Immunol       Date:  2000-11       Impact factor: 25.606

Review 2.  CD27 and CD70 in T cell and B cell activation.

Authors:  Jannie Borst; Jenny Hendriks; Yanling Xiao
Journal:  Curr Opin Immunol       Date:  2005-06       Impact factor: 7.486

3.  During viral infection of the respiratory tract, CD27, 4-1BB, and OX40 collectively determine formation of CD8+ memory T cells and their capacity for secondary expansion.

Authors:  Jenny Hendriks; Yanling Xiao; John W A Rossen; Koenraad F van der Sluijs; Kazuo Sugamura; Naoto Ishii; Jannie Borst
Journal:  J Immunol       Date:  2005-08-01       Impact factor: 5.422

4.  Combined TLR/CD40 stimulation mediates potent cellular immunity by regulating dendritic cell expression of CD70 in vivo.

Authors:  Phillip J Sanchez; Jennifer A McWilliams; Catherine Haluszczak; Hideo Yagita; Ross M Kedl
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

Review 5.  TNF/TNFR family members in costimulation of T cell responses.

Authors:  Tania H Watts
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

6.  OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells.

Authors:  P R Rogers; J Song; I Gramaglia; N Killeen; M Croft
Journal:  Immunity       Date:  2001-09       Impact factor: 31.745

7.  Induction of CD70 on dendritic cells through CD40 or TLR stimulation contributes to the development of CD8+ T cell responses in the absence of CD4+ T cells.

Authors:  Timothy N J Bullock; Hideo Yagita
Journal:  J Immunol       Date:  2005-01-15       Impact factor: 5.422

8.  Expression of the murine CD27 ligand CD70 in vitro and in vivo.

Authors:  Kiki Tesselaar; Yanling Xiao; Ramon Arens; Gijs M W van Schijndel; Danita H Schuurhuis; Reina E Mebius; Jannie Borst; René A W van Lier
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

9.  4-1BB promotes the survival of CD8+ T lymphocytes by increasing expression of Bcl-xL and Bfl-1.

Authors:  Hyeon-Woo Lee; Su-Jung Park; Beom K Choi; Hyun Hwa Kim; Kyung-Ok Nam; Byoung S Kwon
Journal:  J Immunol       Date:  2002-11-01       Impact factor: 5.422

10.  A subset of dendritic cells induces CD4+ T cells to produce IFN-gamma by an IL-12-independent but CD70-dependent mechanism in vivo.

Authors:  Helena Soares; HaeNa Waechter; Nicholas Glaichenhaus; Evelyne Mougneau; Hideo Yagita; Olga Mizenina; Diana Dudziak; Michel C Nussenzweig; Ralph M Steinman
Journal:  J Exp Med       Date:  2007-04-16       Impact factor: 14.307

View more
  6 in total

Review 1.  Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts.

Authors:  Yuchen Wang; Hao Zhang; Chao Liu; Zeyu Wang; Wantao Wu; Nan Zhang; Longbo Zhang; Jason Hu; Peng Luo; Jian Zhang; Zaoqu Liu; Yun Peng; Zhixiong Liu; Lanhua Tang; Quan Cheng
Journal:  J Hematol Oncol       Date:  2022-08-17       Impact factor: 23.168

2.  Identification of an Immune Gene-Based Cisplatin Response Model and CD27 as a Therapeutic Target against Cisplatin Resistance for Ovarian Cancer.

Authors:  Ying Guo; Na Yang; Gang Li; Xiurong Yin; Lixia Dong
Journal:  J Immunol Res       Date:  2022-05-18       Impact factor: 4.493

3.  CITEMOXMBD: A flexible single-cell multimodal omics analysis framework to reveal the heterogeneity of immune cells.

Authors:  Huan Hu; Ruiqi Liu; Chunlin Zhao; Yuer Lu; Yichun Xiong; Lingling Chen; Jun Jin; Yunlong Ma; Jianzhong Su; Zhengquan Yu; Feng Cheng; Fangfu Ye; Liyu Liu; Qi Zhao; Jianwei Shuai
Journal:  RNA Biol       Date:  2022-01       Impact factor: 4.652

Review 4.  Targeting the CD27-CD70 Pathway to Improve Outcomes in Both Checkpoint Immunotherapy and Allogeneic Hematopoietic Cell Transplantation.

Authors:  Forat Lutfi; Long Wu; Sarah Sunshine; Xuefang Cao
Journal:  Front Immunol       Date:  2021-09-22       Impact factor: 8.786

5.  Prognostic impacts of soluble immune checkpoint regulators and cytokines in patients with SARS-CoV-2 infection.

Authors:  Nuri Lee; Seri Jeong; Kibum Jeon; Min-Jeong Park; Wonkeun Song
Journal:  Front Immunol       Date:  2022-08-15       Impact factor: 8.786

6.  Assessment of CD27 expression on T-cells as a diagnostic and therapeutic tool for patients with smear-negative pulmonary tuberculosis.

Authors:  Haiyun Zhang; Xiaoyan Si; Feifan Xu; Junlin Chen; Yuhao Chen; Xiaopeng Cui; Yongwei Qin
Journal:  BMC Immunol       Date:  2021-06-27       Impact factor: 3.615

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.